EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) have been assigned an average recommendation of “Buy” from the five analysts that are presently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objective among analysts that have updated their coverage on […]

Leave a Reply

Your email address will not be published.

Previous post Critical Survey: Lenovo Group (OTCMKTS:LNVGF) vs. Corsair Gaming (NASDAQ:CRSR)
Next post Financial Comparison: TradeUP Acquisition (NASDAQ:UPTD) & Dyadic International (NASDAQ:DYAI)